These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16870716)

  • 21. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
    Zhang X; Wei H; Chen Q; Tian Z
    Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An orthotopic mouse model of remetastasis of human colon cancer liver metastasis.
    Rashidi B; Gamagami R; Sasson A; Sun FX; Geller J; Moossa AR; Hoffman RM
    Clin Cancer Res; 2000 Jun; 6(6):2556-61. PubMed ID: 10873112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
    Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
    Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury.
    Rancan M; Bye N; Otto VI; Trentz O; Kossmann T; Frentzel S; Morganti-Kossmann MC
    J Cereb Blood Flow Metab; 2004 Oct; 24(10):1110-8. PubMed ID: 15529011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF-alpha and IL-4 regulate expression of fractalkine (CX3CL1) as a membrane-anchored proadhesive protein and soluble chemotactic peptide on human fibroblasts.
    Yoshikawa M; Nakajima T; Matsumoto K; Okada N; Tsukidate T; Iida M; Otori N; Haruna S; Moriyama H; Imai T; Saito H
    FEBS Lett; 2004 Mar; 561(1-3):105-10. PubMed ID: 15013759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.
    Kikuchi T; Andarini S; Xin H; Gomi K; Tokue Y; Saijo Y; Honjo T; Watanabe A; Nukiwa T
    Infect Immun; 2005 Sep; 73(9):5350-7. PubMed ID: 16113250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
    Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
    J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental gene therapy mediated by fractalkine (FK) for murine liver cancer].
    Tang L; Hu P; Hu HD; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):675-7. PubMed ID: 16174457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.
    Combadiere C; Gao J; Tiffany HL; Murphy PM
    Biochem Biophys Res Commun; 1998 Dec; 253(3):728-32. PubMed ID: 9918795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence.
    Fujimoto K; Imaizumi T; Yoshida H; Takanashi S; Okumura K; Satoh K
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):233-8. PubMed ID: 11509334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis.
    Hara Y; Ogata Y; Shirouzu K
    J Exp Clin Cancer Res; 2000 Dec; 19(4):497-504. PubMed ID: 11277329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
    Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Matsubara T; Ono T; Yamanoi A; Tachibana M; Nagasue N
    J Surg Oncol; 2007 Mar; 95(3):241-9. PubMed ID: 17323338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CX(3)C chemokine fractalkine in pulmonary arterial hypertension.
    Balabanian K; Foussat A; Dorfmüller P; Durand-Gasselin I; Capel F; Bouchet-Delbos L; Portier A; Marfaing-Koka A; Krzysiek R; Rimaniol AC; Simonneau G; Emilie D; Humbert M
    Am J Respir Crit Care Med; 2002 May; 165(10):1419-25. PubMed ID: 12016106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractalkine: moving from chemotaxis to neuroprotection.
    Ré DB; Przedborski S
    Nat Neurosci; 2006 Jul; 9(7):859-61. PubMed ID: 16801915
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fractalkine and inflammatory diseases].
    Imai T; Nishimura M; Nanki T; Umehara H
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):131-9. PubMed ID: 15997176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractalkine mediates natural killer-dependent antitumor responses in vivo.
    Lavergne E; Combadière B; Bonduelle O; Iga M; Gao JL; Maho M; Boissonnas A; Murphy PM; Debré P; Combadière C
    Cancer Res; 2003 Nov; 63(21):7468-74. PubMed ID: 14612547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation.
    Kubota T
    J Cell Biochem; 1994 Sep; 56(1):4-8. PubMed ID: 7806591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.
    Meijer J; Zeelenberg IS; Sipos B; Roos E
    Cancer Res; 2006 Oct; 66(19):9576-82. PubMed ID: 17018614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.